A systematic review of growth hormone for hip fractures

Growth Hormone and IGF Research

Volumn 22, Issue 3-4, 2012, Pages 97-101

  Yang, Shengping ^a   Cao, Liying ^a   Cai, Shumei ^a   Yuan, Jinqiu ^b   Wang, Jianmin ^a  

^a LANZHOU UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Growth hormone; Hip fractures; Systematic review

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN;

ACUTE KIDNEY FAILURE; AGE; AGED; BONE MINERAL; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DATA BASE; DRUG FATALITY; EDEMA; EMBASE; EVIDENCE BASED PRACTICE; FEMALE; HEART INFARCTION; HIP FRACTURE; HORMONAL THERAPY; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDLINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

EID: 84863774804     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.03.002     Document Type: Review

References (25)

1. Kato Y., Murakami Y., Sohmiya M., Nishiki M. Regulation of human growth hormone secretion and its disorders. Internal Medicine-Tokyo-Japanese Society of Internal Medicine 2002, 41(1):7-13.
2. Ohlsson C., Bengtsson B.A., Isaksson O.G.P., Andreassen T.T., Slootweg M.C. Growth hormone and bone. Endocr Rev. 1998, 19(1):55-79.
3. Chihara K., Sugimoto T. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts. Horm Res. 1997, 48:45-49.
4. Bail H.J., Kolbeck S., Krummrey G., et al. Systemic application of growth hormone for enhancement of secondary and intramembranous fracture healing. Horm Res. 2002, 58:39-42.
5. Zuckerman J.D., Rosenberg A.D. Hip fracture. New Engl J Med. 1996, 335(26):1995-1996.
6. Marks R. Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009. Int J Gen Med. 2010, 3:1-17.
7. Guide to research methods: the evidence pyramid available from http://library.downstate.edu/EBM2/2100.htm.
8. Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001, 323(7308):334.
9. Y.P. li, T.J. Tao, D. Sun, et al., A pilot study of the classification of Chinese Medical Specialty, Chinese Journal of Evidence-Based Medicine. 4 (3) (1994) 173-180.
10. J. P. T. Higgins, S. Green, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [Updated September 2009] The Cochrane Collaboration (2009) Available from http://www.cochranehand-book.org.
11. Berlin J.A. Does blinding of readers affect the results of meta-analyses?. Lancet. 1997, 350(9072):185-186.
12. Higgins J.P.T., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21(11):1539-1558.
13. Chevalley T., Hoffmeyer P., Bonjour J.P., Rizzoli R. Early serum IGF-I response to oral protein supplements in elderly women with a recent hip fracture. Clinical Nutrition. 2010, 29(1):78-83.
14. Wang K., Zhu L., Lu H.D., Cai D.Z. Effect of reconstructed growth hormone on hip arthroplasty of the aged patients. Orthopedic Journal of China. 2005, 13(4):273-275.
15. Bach M.A., Rockwood K., Zetterberg C., et al. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J Am Geriatr Soc. 2004, 52(4):516-523.
16. Hedström M., Ljungqvist O., Cederholm T. Metabolism and catabolism in hip fracture patients: nutritional and anabolic intervention - a review. Acta orthopaedica. 2006, 77(5):741-747.
17. A. Adunsky, J. Chandler, N. Heyden, et al., MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study, Archives of Gerontology and Geriatrics (2010).
18. Schurch M.A., Rizzoli R., Slosman D., et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. Annals of internal medicine. 1998, 128(10):801.
19. Yeo A.L., Levy D., Martin F.C., et al. Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture. Growth Horm Igf Res. 2003, 13(6):361-370.
20. Hedström M., Saaf M., Brosjo E., et al. Positive effects of short-term growth hormone treatment on bean body mass and BMC after a hip fracture - a double-blind placebo-controlled pilot study in 20 patients. Acta Orthop Scand. 2004, 75(4):394-401.
21. Van der Lely A.J., Lamberts S.W., Jauch K.W., et al. Use of human GH in elderly patients with accidental hip fracture. Eur J Endocrinol. 2000, 143(5):585-592.
22. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6(7):e1000097.
23. Wu T.X., Liu G.J., Li J. Some risks of affecting the quality of published systematic reviews in China. Chinese Journal of Evidence-Based Medicine. 2005, 5(1):51-58.
24. Keene G.S., Parker M.J., Pryor G.A. Mortality and morbidity after hip fractures. BMJ. 1993, 307(6914):1248-1250.
25. Raschke M., Rasmussen M.H., Govender S., et al. Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial. Eur J Endocrinol. 2007, 156(3):341-351.